These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 33176143)

  • 1. Loss of Muscle Carnitine Palmitoyltransferase 2 Prevents Diet-Induced Obesity and Insulin Resistance despite Long-Chain Acylcarnitine Accumulation.
    Pereyra AS; Rajan A; Ferreira CR; Ellis JM
    Cell Rep; 2020 Nov; 33(6):108374. PubMed ID: 33176143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octanoate is differentially metabolized in liver and muscle and fails to rescue cardiomyopathy in CPT2 deficiency.
    Pereyra AS; Harris KL; Soepriatna AH; Waterbury QA; Bharathi SS; Zhang Y; Fisher-Wellman KH; Goergen CJ; Goetzman ES; Ellis JM
    J Lipid Res; 2021; 62():100069. PubMed ID: 33757734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine palmitoyltransferase 2 knockout potentiates palmitate-induced insulin resistance in C
    Blackburn ML; Ono-Moore KD; Sobhi HF; Adams SH
    Am J Physiol Endocrinol Metab; 2020 Aug; 319(2):E265-E275. PubMed ID: 32459525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine palmitoyltransferase 2: New insights on the substrate specificity and implications for acylcarnitine profiling.
    Violante S; Ijlst L; van Lenthe H; de Almeida IT; Wanders RJ; Ventura FV
    Biochim Biophys Acta; 2010 Sep; 1802(9):728-32. PubMed ID: 20538056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity.
    Fujiwara N; Nakagawa H; Enooku K; Kudo Y; Hayata Y; Nakatsuka T; Tanaka Y; Tateishi R; Hikiba Y; Misumi K; Tanaka M; Hayashi A; Shibahara J; Fukayama M; Arita J; Hasegawa K; Hirschfield H; Hoshida Y; Hirata Y; Otsuka M; Tateishi K; Koike K
    Gut; 2018 Aug; 67(8):1493-1504. PubMed ID: 29437870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-chain acylcarnitines determine ischaemia/reperfusion-induced damage in heart mitochondria.
    Liepinsh E; Makrecka-Kuka M; Volska K; Kuka J; Makarova E; Antone U; Sevostjanovs E; Vilskersts R; Strods A; Tars K; Dambrova M
    Biochem J; 2016 May; 473(9):1191-202. PubMed ID: 26936967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines.
    Violante S; Ijlst L; Te Brinke H; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
    FASEB J; 2013 May; 27(5):2039-44. PubMed ID: 23322164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
    Violante S; Ijlst L; Te Brinke H; Koster J; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
    Biochim Biophys Acta; 2013 Sep; 1831(9):1467-74. PubMed ID: 23850792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of mitochondria long-chain fatty acid oxidation impairs skeletal muscle contractility by disrupting myofibril structure and calcium homeostasis.
    Pereyra AS; Fernandez RF; Amorese A; Castro JN; Lin CT; Spangenburg EE; Ellis JM
    Mol Metab; 2024 Nov; 89():102015. PubMed ID: 39182841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acylcarnitines: potential implications for skeletal muscle insulin resistance.
    Aguer C; McCoin CS; Knotts TA; Thrush AB; Ono-Moore K; McPherson R; Dent R; Hwang DH; Adams SH; Harper ME
    FASEB J; 2015 Jan; 29(1):336-45. PubMed ID: 25342132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate specificity of human carnitine acetyltransferase: Implications for fatty acid and branched-chain amino acid metabolism.
    Violante S; Ijlst L; Ruiter J; Koster J; van Lenthe H; Duran M; de Almeida IT; Wanders RJ; Houten SM; Ventura FV
    Biochim Biophys Acta; 2013 Jun; 1832(6):773-9. PubMed ID: 23485643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice.
    Keung W; Ussher JR; Jaswal JS; Raubenheimer M; Lam VH; Wagg CS; Lopaschuk GD
    Diabetes; 2013 Mar; 62(3):711-20. PubMed ID: 23139350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of altered carnitine availability on acylcarnitine metabolism, energy expenditure and glucose tolerance in diet-induced obese mice.
    Schooneman MG; Houtkooper RH; Hollak CE; Wanders RJ; Vaz FM; Soeters MR; Houten SM
    Biochim Biophys Acta; 2016 Aug; 1862(8):1375-82. PubMed ID: 27112275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance.
    Bruce CR; Hoy AJ; Turner N; Watt MJ; Allen TL; Carpenter K; Cooney GJ; Febbraio MA; Kraegen EW
    Diabetes; 2009 Mar; 58(3):550-8. PubMed ID: 19073774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic profiling analysis upon acylcarnitines in tissues of hepatocellular carcinoma revealed the inhibited carnitine shuttle system caused by the downregulated carnitine palmitoyltransferase 2.
    Lu X; Zhang X; Zhang Y; Zhang K; Zhan C; Shi X; Li Y; Zhao J; Bai Y; Wang Y; Nie H; Li Y
    Mol Carcinog; 2019 May; 58(5):749-759. PubMed ID: 30604893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons.
    Zhang J; Light AR; Hoppel CL; Campbell C; Chandler CJ; Burnett DJ; Souza EC; Casazza GA; Hughen RW; Keim NL; Newman JW; Hunter GR; Fernandez JR; Garvey WT; Harper ME; Fiehn O; Adams SH
    Exp Physiol; 2017 Jan; 102(1):48-69. PubMed ID: 27730694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
    Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
    Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator activated receptor delta (PPARdelta) agonist but not PPARalpha corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells.
    Djouadi F; Aubey F; Schlemmer D; Bastin J
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1791-7. PubMed ID: 15613406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle undergoes fiber type metabolic switch without myosin heavy chain switch in response to defective fatty acid oxidation.
    Pereyra AS; Lin CT; Sanchez DM; Laskin J; Spangenburg EE; Neufer PD; Fisher-Wellman K; Ellis JM
    Mol Metab; 2022 May; 59():101456. PubMed ID: 35150906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle expression of a malonyl-CoA-insensitive carnitine palmitoyltransferase-1 protects mice against high-fat/high-sucrose diet-induced insulin resistance.
    Vavrova E; Lenoir V; Alves-Guerra MC; Denis RG; Castel J; Esnous C; Dyck JR; Luquet S; Metzger D; Bouillaud F; Prip-Buus C
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E649-60. PubMed ID: 27507552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.